Cargando…

Development of an Immune-Related LncRNA Prognostic Signature for Glioma

INTRODUCTION: Glioma is the most common primary cancer of the central nervous system with dismal prognosis. Long noncoding RNAs (lncRNAs) have been discovered to play key roles in tumorigenesis in various cancers, including glioma. Because of the relevance between immune infiltrating and clinical ou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Yudong, Zhu, Hecheng, Tan, Jun, Yin, Wen, Zhou, Quanwei, Xin, Zhaoqi, Wu, Zhaoping, Jiang, Zhipeng, Guo, Youwei, Kuang, Yirui, Li, Can, Zhao, Ming, Jiang, Xingjun, Peng, Jiahui, Ren, Caiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238205/ https://www.ncbi.nlm.nih.gov/pubmed/34194477 http://dx.doi.org/10.3389/fgene.2021.678436

Ejemplares similares

Molecular Subtypes Based on the Stemness Index Predict Prognosis in Glioma Patients
por: Tan, Jun, et al.
Publicado: (2021)

METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis
por: Jiang, Zhipeng, et al.
Publicado: (2021)

Multi-Omics Analysis Based on Genomic Instability for Prognostic Prediction in Lower-Grade Glioma
por: Cao, Yudong, et al.
Publicado: (2022)

Identification of cuproptosis-related subtypes and the development of a prognostic model in glioma
por: Wu, Zhaoping, et al.
Publicado: (2023)

Development and Validation of a Tumor Mutation Burden–Related Immune Prognostic Model for Lower-Grade Glioma
por: Yin, Wen, et al.
Publicado: (2020)

A prognostic signature based on snoRNA predicts the overall survival of lower-grade glioma patients
por: Zhou, Yi, et al.
Publicado: (2023)

Identification of collagen genes related to immune infiltration and epithelial-mesenchymal transition in glioma
por: Yin, Wen, et al.
Publicado: (2021)

Expression Profile Analysis Identifies a Novel Five-Gene Signature to Improve Prognosis Prediction of Glioblastoma
por: Yin, Wen, et al.
Publicado: (2019)

Identification and validation of ferroptosis-related lncRNA signatures as a novel prognostic model for glioma
por: Huang, Liang, et al.
Publicado: (2022)

Identification of three tumor antigens and immune subtypes for mRNA vaccine development in diffuse glioma
por: Zhou, Quanwei, et al.
Publicado: (2021)

Construction and experimental validation of a signature for predicting prognosis and immune infiltration analysis of glioma based on disulfidptosis-related lncRNAs
por: Guo, Youwei, et al.
Publicado: (2023)

An Immune Gene-Related Five-lncRNA Signature for to Predict Glioma Prognosis
por: Wang, Xinzhuang, et al.
Publicado: (2020)

Integrated analysis of inflammatory response subtype-related signature to predict clinical outcomes, immune status and drug targets in lower-grade glioma
por: Cao, Yudong, et al.
Publicado: (2022)

The clinical features, prognostic significance, and immune heterogeneity of CD37 in diffuse gliomas
por: Yan, Xuejun, et al.
Publicado: (2021)

Six-lncRNA Immune Prognostic Signature for Cervical Cancer
por: Chen, Qian, et al.
Publicado: (2020)

A four-lncRNA risk signature for prognostic prediction of osteosarcoma
por: Liu, Huanlong, et al.
Publicado: (2023)

Prognosis and immune response of a cuproptosis-related lncRNA signature in low grade glioma
por: Xu, Yifan, et al.
Publicado: (2022)

Identification and Validation of EMT-Related lncRNA Prognostic Signature for Colorectal Cancer
por: Li, Danfeng, et al.
Publicado: (2021)

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021)

Identification of a Six-lncRNA Signature With Prognostic Value for Breast Cancer Patients
por: Zhao, Erjie, et al.
Publicado: (2020)

Prognostic lncRNA, miRNA, and mRNA Signatures in Papillary Thyroid Carcinoma
por: Wang, Kun, et al.
Publicado: (2020)

Identification of genomic instability related lncRNA signature with prognostic value and its role in cancer immunotherapy in pancreatic cancer
por: Zhu, Xiaole, et al.
Publicado: (2022)

A Six-lncRNA Signature for Immunophenotype Prediction of Glioblastoma Multiforme
por: Gao, Ming, et al.
Publicado: (2021)

A prognostic pyroptosis-related LncRNA classifier associated with the immune landscape and therapy efficacy in glioma
por: Zhong, Jiasheng, et al.
Publicado: (2022)

Identification and Validation of Hypoxia-Related lncRNA Signature as a Prognostic Model for Hepatocellular Carcinoma
por: Zhou, Chenghui, et al.
Publicado: (2021)

Discovery and Validation of a Novel Metastasis-Related lncRNA Prognostic Signature for Colorectal Cancer
por: Tang, Qiang, et al.
Publicado: (2022)

A novel prognostic signature based on cuproptosis-related lncRNA mining in colorectal cancer
por: Hou, Dong, et al.
Publicado: (2022)

A Novel Ferroptosis-Related LncRNA Pair Prognostic Signature Predicts Immune Landscapes and Treatment Responses for Gastric Cancer Patients
por: Li, Jiazheng, et al.
Publicado: (2022)

Corrigendum: A novel ferroptosis-related LncRNA pair prognostic signature predicts immune landscapes and treatment responses for gastric cancer patients
por: Li, Jiazheng, et al.
Publicado: (2022)

Prognostic Ferroptosis-Related lncRNA Signatures Associated With Immunotherapy and Chemotherapy Responses in Patients With Stomach Cancer
por: Lai, Donglin, et al.
Publicado: (2022)

Identification of an Autophagy-Related lncRNA Prognostic Signature and Related Tumor Immunity Research in Lung Adenocarcinoma
por: Chen, Hang, et al.
Publicado: (2021)

Analysis of Pyroptosis-Related Immune Signatures and Identification of Pyroptosis-Related LncRNA Prognostic Signature in Clear Cell Renal Cell Carcinoma
por: Zhong, Ming, et al.
Publicado: (2022)

Integrated Analysis of lncRNA-Mediated ceRNA Network Reveals a Prognostic Signature for Hepatocellular Carcinoma
por: Sun, Jian-Rong, et al.
Publicado: (2020)

Corrigendum: Prognostic ferroptosis-related lncRNA signatures associated with immunotherapy and chemotherapy responses in patients with stomach cancer
por: Lai, Donglin, et al.
Publicado: (2022)

A Novel Inflammatory lncRNAs Prognostic Signature for Predicting the Prognosis of Low-Grade Glioma Patients
por: Xiang, Zijin, et al.
Publicado: (2021)

A novel necroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma
por: Wang, Jianguo, et al.
Publicado: (2022)

A practical and economical method for frontal sinus reconstruction after frontal craniotomy: A single-center experience with 140 patients
por: Guo, Youwei, et al.
Publicado: (2022)

Data Mining and Expression Analysis of Differential lncRNA ADAMTS9-AS1 in Prostate Cancer
por: Wan, Jiahui, et al.
Publicado: (2020)

Construction of a ceRNA-based lncRNA–mRNA network to identify functional lncRNAs in premature ovarian insufficiency
por: Luo, Chao, et al.
Publicado: (2022)

The prognostic value and immune landscape of a cuproptosis-related lncRNA signature in head and neck squamous cell carcinoma
por: Li, Yao jun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_if0752339ro1q0ctkv8sqslfke